Literature DB >> 3329095

Human hypervariable sequences in risk assessment: rare Ha-ras alleles in cancer patients.

T G Krontiris1, N A DiMartino, H D Mitcheson, J A Lonergan, C Begg, D R Parkinson.   

Abstract

A variable tandem repeat (VTR) is responsible for the hyperallelism one kilobase 3' to the human c-Ha-ras-1 (Ha-ras) gene. Thirty-two distinct restriction fragments, comprising 3 allelic classes by frequency of occurrence, have thus far been detected in a sample size of approximately 800 caucasians. Rare Ha-ras alleles, 21 in all, are almost exclusively confined to the genomes of cancer patients (p less than 0.001). From our data we have computed the relative cancer risk associated with possession of a rare Ha-ras allele to be 27. To understand the molecular basis for this phenomenon, we have begun to clone Ha-ras fragments from nontumor DNA of cancer patients. We report here the weak activation, as detected by transfection and transformation of NIH 3T3 mouse cells, of two Ha-ras genes which were obtained from lymphocyte DNA of a melanoma patient. We have mapped the regions that confer this transforming activity to the fragment containing the VTR in one Ha-ras clone and the fragment containing gene coding sequences in the other.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3329095      PMCID: PMC1474469          DOI: 10.1289/ehp.8776147

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  15 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients.

Authors:  T G Krontiris; N A DiMartino; M Colb; D R Parkinson
Journal:  Nature       Date:  1985 Jan 31-Feb 6       Impact factor: 49.962

3.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

4.  Isolation of a transforming sequence from a human bladder carcinoma cell line.

Authors:  C Shih; R A Weinberg
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

Review 5.  The molecular genetics of cellular oncogenes.

Authors:  H E Varmus
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

6.  Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhood.

Authors:  S Rodenhuis; J L Bos; R M Slater; H Behrendt; M van 't Veer; L A Smets
Journal:  Blood       Date:  1986-06       Impact factor: 22.113

7.  Ha-ras hypervariable alleles in myelodysplasia.

Authors:  S L Thein; D G Oscier; J Flint; J S Wainscoat
Journal:  Nature       Date:  1986 May 1-7       Impact factor: 49.962

8.  Human restriction fragment length polymorphisms and cancer risk assessment.

Authors:  T G Krontiris; N A DiMartino; M Colb; H D Mitcheson; D R Parkinson
Journal:  J Cell Biochem       Date:  1986       Impact factor: 4.429

9.  Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus.

Authors:  E H Chang; M E Furth; E M Scolnick; D R Lowy
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

10.  Genetic predisposition to human lung cancer.

Authors:  J Heighway; N Thatcher; T Cerny; P S Hasleton
Journal:  Br J Cancer       Date:  1986-04       Impact factor: 7.640

View more
  8 in total

1.  Minisatellite allele diversification: the origin of rare alleles at the HRAS1 locus.

Authors:  A Kasperczyk; N A DiMartino; T G Krontiris
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

2.  ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S.

Authors:  J Coburn; D M Gill
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

3.  Allele-specific deletion in exon I of the HRAS1 gene.

Authors:  A Kasperczyk; B A Mermer; D R Parkinson; J A Lonergan; T G Krontiris
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

4.  Distribution of Ha-ras alleles in patients with colorectal cancer and Crohn's disease.

Authors:  R Klingel; P Mittelstaedt; W G Dippold; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

5.  Analysis of Ha-ras 1 allele frequencies in hereditary non-polyposis colorectal cancer.

Authors:  P Jeevaratnam; P J Browett; N S Van de Water; J R Jass
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

Review 6.  Genetics of primary brain tumors: a review.

Authors:  M Bondy; J Wiencke; M Wrensch; A P Kyritsis
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Ha-ras-1 alleles in Norwegian lung cancer patients.

Authors:  D Ryberg; T Tefre; S Ovrebø; V Skaug; L Stangeland; A Naalsund; R Baera; A L Børresen; A Haugen
Journal:  Hum Genet       Date:  1990-11       Impact factor: 4.132

8.  Allele diversity of the H-ras-1 variable number of tandem repeats in Norwegian lung cancer patients.

Authors:  D Ryberg; T Tefre; V Skaug; L Stangeland; S Ovrebø; A Naalsund; A L Børresen; A Haugen
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.